Solvay SA
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Philippe Kehren
- Full Time Employees
- 8,443
- Sector
- Process industries
- Industry
- Chemicals: specialty
- Address
- Rue de Ransbeek, 310 Brussels BU Belgium 1120
- IPO Date
- Jan 23, 2012
- Website
- solvay.com
- Similar Companies
- Business
- Solvay S.A. Solvay SA is a Belgium-based chemical company focused on the production and sale of essential chemicals serving resilient global markets including consumer goods, healthcare, food, electronics, building and construction, automotive, and industrial applications. Founded in 1863 and headquartered in Brussels, the company operates manufacturing facilities in approximately 40 countries across Europe, North America, Latin America, and Asia, employing over 9,000 people; its core portfolio comprises Basic Chemicals such as soda ash and derivatives, sodium bicarbonate, hydrogen peroxide, and Peroxides, alongside Performance Chemicals including highly dispersible silica, Coatis products, Special Chem formulations, solvents, fluorine, rare earths, and phenol, produced through proprietary large-scale processes with vertical integration and customization capabilities. Following the partial demerger completed on December 9, 2023, which separated its specialty chemicals activities into the standalone entity Syensqo, Solvay streamlined into a more focused essential chemicals provider with a new strategy emphasizing operational excellence, process innovation, energy transition toward carbon neutrality by 2050, and capacity expansions in high-growth areas like electronic grade peroxide, circular silica, and rare earths; recent initiatives include portfolio realignment at its Bad Wimpfen site in Germany announced in September 2025 to establish a global hub for Nocolok production with €25 million in investments planned primarily for 2026, ongoing share buyback programs such as the completion of a 1.025 million share repurchase in October 2024 and further acquisitions in March 2025 to support long-term incentive plans, and structural cost savings alongside disciplined investments amid a challenging market environment reflected in Q3 2025 underlying net sales of €1,044 million.
Company News
Solvay cuts 2026 forecast after Middle East conflict hits Q3
Solvay SA (OTCMKTS:SLVYY) Stock Rated “Reduce” by Wall Street Analysts
Solvay to more than double Taiwan chip peroxide capacity, targets tripling electronic-grade business
Solvay SA (SLVYY) Q2 2026 Earnings Call Transcript
Solvay SA (SLVYY) Q1 2026 Earnings Call Transcript
Solvay publishes notice of 2026 Annual General Meeting
Short Interest in Solvay SA (OTCMKTS:SVYSF) Grows By 79.3%
3 Rare Earth Stocks Quietly Building the Next Supply Chain
Solvay: Why I Added To My Position In This High Yielding Stock
Solvay SA (SLVYY) Q4 2025 Earnings Call Transcript
Solvay SA (OTC:SLVYY) Given Average Rating of “Reduce” by Analysts
Solvay: I'm Still A Buyer Of This High-Yielding Chemical Company
Solvay Financial Calendar 2026
USA Rare Earth Subsidiary Less Common Metals and Solvay Sign Strategic Agreement to Provide Permag Secure, Stable Supply of Rare Earth Metals
Solvay of Belgium Creates Rare Earths Deals With U.S.
Solvay SA (SLVYY) Q3 2025 Earnings Call Transcript
Solvay integrates sustainability-linked features in all short-term liquidity reserves
Solvay: A Complex Macro Environment Is Buffered By Elevated Cash Conversion
Solvay strengthens its competitiveness in Germany through portfolio realignment and investments
Solvay SA (SVYSF) Q2 2025 Earnings Call Transcript